Achieving remission in clinical practice: lessons from clinical trial data
- PMID: 23622099
Achieving remission in clinical practice: lessons from clinical trial data
Abstract
This review examines the literature on the frequency of remission associated with different treatment approaches in early rheumatoid arthritis (ERA). Trials reporting remission outcomes were identified through searches of the CINAHL, EMBASE, and Medline (PubMed) databases from 2000 through August 2012. Additional literature was identified through hand searching. The proportion of patients achieving remission and/or radiographic non-progression was extracted from each study. Evidence was examined in the context of unified remission criteria and practical considerations for achieving and maintaining remission are discussed. The literature highlights the benefits of early treatment with disease-modifying anti-rheumatic drug (DMARD) combination therapy, combination therapy with a biologic, and tight control with a pre-specified treatment target in achieving remission in ERA. The added stringency of the 2011 remission criteria may increase the proportion of patients achieving true remission, while identifying predictors of sustained remission may also help patients achieve better radiographic and functional outcomes.
Similar articles
-
Remission in rheumatoid arthritis: wishful thinking or clinical reality?Semin Arthritis Rheum. 2005 Dec;35(3):185-96. doi: 10.1016/j.semarthrit.2005.06.003. Semin Arthritis Rheum. 2005. PMID: 16325659
-
Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH).J Rheumatol. 2014 Nov;41(11):2161-6. doi: 10.3899/jrheum.140137. Epub 2014 Oct 1. J Rheumatol. 2014. PMID: 25274902
-
Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.Arthritis Rheum. 2009 Aug;60(8):2262-71. doi: 10.1002/art.24661. Arthritis Rheum. 2009. PMID: 19644846
-
Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission.Ann Rheum Dis. 2010 Jul;69(7):1298-304. doi: 10.1136/ard.2009.118307. Epub 2010 Apr 26. Ann Rheum Dis. 2010. PMID: 20421343 Review.
-
Is it possible to withdraw biologics from therapy in rheumatoid arthritis?Clin Ther. 2013 Dec;35(12):2028-35. doi: 10.1016/j.clinthera.2013.10.008. Epub 2013 Nov 28. Clin Ther. 2013. PMID: 24290736 Review.
Cited by
-
The impact of different criteria sets on early remission and identifying its predictors in rheumatoid arthritis: results from an observational cohort (2009-2018).Clin Rheumatol. 2020 Feb;39(2):381-389. doi: 10.1007/s10067-019-04807-8. Epub 2019 Nov 11. Clin Rheumatol. 2020. PMID: 31709477
-
Intensive therapy and remissions in rheumatoid arthritis: a systematic review.BMC Musculoskelet Disord. 2018 Oct 30;19(1):389. doi: 10.1186/s12891-018-2302-5. BMC Musculoskelet Disord. 2018. PMID: 30376836 Free PMC article.
-
Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.Clin Rheumatol. 2018 Feb;37(2):315-321. doi: 10.1007/s10067-017-3846-8. Epub 2017 Oct 5. Clin Rheumatol. 2018. PMID: 28980085
-
Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?Am J Transl Res. 2017 Aug 15;9(8):3758-3775. eCollection 2017. Am J Transl Res. 2017. PMID: 28861167 Free PMC article.
-
Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review.Ther Clin Risk Manag. 2016 Nov 21;12:1763-1776. doi: 10.2147/TCRM.S112685. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27920546 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
